The value of the 3D Cell Culture market is projected to grow to USD 4640.49 Million with an estimated CAGR of 13.94 % by 2030
Growth in the acceptance of organ transplantation and tissue engineering for chronic diseases is anticipated to fuel the research during the forecast period. Moreover, for implementing the culture by using micro-fabricated tissue component is projected to offer the 3D cell culture market with various opportunities. For the better representation, it is very important to incorporate the 3D cell culture system in the activities of research are fueling the development of new methods and materials, boosting the global 3D cell culture market growth.
3D cell culture market trends are increasing in the occurrence of cancer. Use of 3D cultures in the detection of the phenotypic changes is encouraging the acceptance of healthcare facilities and the activities of R&D. The advantages completed by the use of 3D in the stem cells and oncology are providing various opportunities leveraged for the development of 3D cell culture in the therapeutic purposes in the future. 3D cell culture is appropriate for the modeling because of the similarity they offer to the morphology of cells or organs. Various options of 3D cell culture are available on the basis of scaffold-free, 3D bioreactor system and scaffold-based. The appearance of the protocols, kits, and 3D optimized assays with the maturity in the different assay techniques development is propelled to supplement the 3D cell culture market growth.
Increase in the research activities related to the rise in the organizations investing in the development of 3D cell culture is expected to boost the 3D cell culture market across the globe. Investments by the research organizations and manufacturers, 3D cell culture market is burgeoning because of the growth in the demand for the organ transplantation. This is expected to be the important factors responsible for the growth of 3D cell culture market. Using the animals in the testing and the research activities of pharmaceuticals, where 3D cell culture can be a substitute for an animal used for the testing and research purpose and will play a major role in the development of 3D cell culture market in the coming years. Laboratories, biotechnology entities, hospitals, pharma companies, and research institutes are progressively developing the 3D cell culture market. Growth in the usage of the 3D cell culture technique in pharmaceuticals for studying the drug doses impact will foster the 3D cell culture market during the forecast period.
Global 3D cell culture market was segmented into end-user, application, product type, and region. Based on end-user, 3D cell culture market is divided into academic institutes, contract research laboratories, and pharmaceutical & biotechnology companies. Based on application, the market is divided into regenerative medicine, drug discovery, stem cell research, and cancer research. On the basis of product type, the market is divided into services, microchips, bioreactors, gels, and scaffold-based platforms. Scaffold-based platforms are further sub-divided into scaffold-free platforms, solid scaffolds, nano-porous scaffolds, micro-porous scaffolds, and macro-porous scaffolds.
Geographically, regions involved in the global 3D Cell Culture market are Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. Europe is dominating the 3D cell culture market. North America holds the largest 3D cell culture market share.
Key players involved in the global 3D cell culture market are Thermo Fisher Scientific, Nanofiber Solutions, Advanced Biomatrix, Dickinson and Company and more.
3D Cell Culture Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2030||USD 4640.49 Million|
|Growth Rate||CAGR of 13.94% during 2020-2030|
|Segment Covered||Type, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and Africa|
|Key Players Profiled||Merck, 3D Biotek LLC, 3D Biomatrix, Nano3D Biosciences Corning Inc., VWR International, LLC, Thermo Fisher Scientific, Global Cell Solutions, Inc., Becton Dickinson and Company, Tecan, InSphero AG and Lonza Group.|
Key Segments in the “Global 3D Cell Culture Market” are-
By End-User, market is segmented into:
- Academic institutes
- Contract research laboratories
- Pharmaceutical & biotechnology companies
By Application, market is segmented into:
- Regenerative medicine
- Drug discovery
- Stem cell research
- Cancer research
By Product Type, market is segmented into:
- Scaffold-based platforms
- Scaffold-free platforms
- Solid scaffolds
- Nano-porous scaffolds
- Micro-porous scaffolds
- Macro-porous scaffolds
By Regions market is segmented into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa